Previous Article | Next Article 
Molecular and Cellular Biology, March 2000, p. 1911-1922, Vol. 20, No. 6
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
BSAP Can Repress Enhancer Activity by Targeting PU.1
Function
Shanak
Maitra and
Michael
Atchison*
Department of Animal Biology, School of
Veterinary Medicine, University of Pennsylvania, Philadelphia,
Pennsylvania 19104
Received 24 May 1999/Returned for modification 6 July 1999/Accepted 8 December 1999
PU.1 and BSAP are transcription factors crucial for proper B-cell
development. Absence of PU.1 results in loss of B, T, and myeloid
cells, while absence of BSAP results in an early block in B-cell
differentiation. Both of these proteins bind to the immunoglobulin
chain 3' enhancer, which is developmentally regulated during B-cell
differentiation. We find here that BSAP can repress 3' enhancer
activity. This repression can occur in plasmacytoma lines or in a
non-B-cell line in which the enhancer is activated by addition of the
appropriate enhancer binding transcription factors. We show that the
transcription factor PU.1 is a target of the BSAP-mediated repression.
Although PU.1 and BSAP can physically interact through their respective
DNA binding domains, this interaction does not affect DNA binding. When
PU.1 function is assayed in isolation on a multimerized PU.1 binding
site, BSAP targets a portion of the PU.1 transactivation domain
(residues 7 to 30) for repression. The BSAP inhibitory domain (residues
358 to 385) is needed for this repression. Interestingly, the
coactivator protein p300 can eliminate this BSAP-mediated repression.
We also show that PU.1 can inhibit BSAP transactivation and that this repression requires PU.1 amino acids 7 to 30. Transfection of p300
resulted in only a partial reversal of PU.1-mediated repression of
BSAP. When PU.1 function is assayed in the context of the
immunoglobulin
chain 3' enhancer and associated binding proteins,
BSAP represses PU.1 function by a distinct mechanism. This repression
does not require the PU.1 transactivation or PEST domains and cannot be reversed by p300 expression. The possible roles of BSAP and PU.1 antagonistic activities in hematopoietic development are discussed.
*
Corresponding author. Mailing address: School of
Veterinary Medicine, University of Pennsylvania, 3800 Spruce St.,
Philadelphia, PA 19104. Phone: (215) 898-6428. Fax: (215)
573-5189. E-mail: atchison{at}vet.upenn.edu.
Molecular and Cellular Biology, March 2000, p. 1911-1922, Vol. 20, No. 6
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dahl, R., Iyer, S. R., Owens, K. S., Cuylear, D. D., Simon, M. C.
(2007). The Transcriptional Repressor GFI-1 Antagonizes PU.1 Activity through Protein-Protein Interaction. J. Biol. Chem.
282: 6473-6483
[Abstract]
[Full Text]
-
Jimenez-Ramirez, C., Brooks, A. J., Forshell, L. P., Yakimchuk, K., Zhao, B., Fulgham, T. Z., Sample, C. E.
(2006). Epstein-Barr Virus EBNA-3C Is Targeted to and Regulates Expression from the Bidirectional LMP-1/2B Promoter. J. Virol.
80: 11200-11208
[Abstract]
[Full Text]
-
Hodawadekar, S., Wei, F., Yu, D., Thomas-Tikhonenko, A., Atchison, M. L.
(2006). Epigenetic Histone Modifications Do Not Control Ig{kappa} Locus Contraction and Intranuclear Localization in Cells with Dual B Cell-Macrophage Potential. J. Immunol.
177: 6165-6171
[Abstract]
[Full Text]
-
Pang, L., Xue, H.-H., Szalai, G., Wang, X., Wang, Y., Watson, D. K., Leonard, W. J., Blobel, G. A., Poncz, M.
(2006). Maturation stage-specific regulation of megakaryopoiesis by pointed-domain Ets proteins. Blood
108: 2198-2206
[Abstract]
[Full Text]
-
Pawlitzky, I., Angeles, C. V., Siegel, A. M., Stanton, M. L., Riblet, R., Brodeur, P. H.
(2006). Identification of a Candidate Regulatory Element within the 5' Flanking Region of the Mouse Igh Locus Defined by Pro-B Cell-Specific Hypersensitivity Associated with Binding of PU.1, Pax5, and E2A.. J. Immunol.
176: 6839-6851
[Abstract]
[Full Text]
-
Bai, Y., Srinivasan, L., Perkins, L., Atchison, M. L.
(2005). Protein Acetylation Regulates Both PU.1 Transactivation and Ig{kappa} 3' Enhancer Activity. J. Immunol.
175: 5160-5169
[Abstract]
[Full Text]
-
Bruun, J.-A., Thomassen, E. I. S., Kristiansen, K., Tylden, G., Holm, T., Mikkola, I., Bjorkoy, G., Johansen, T.
(2005). The third helix of the homeodomain of paired class homeodomain proteins acts as a recognition helix both for DNA and protein interactions. Nucleic Acids Res
33: 2661-2675
[Abstract]
[Full Text]
-
Liu, Z., Garrard, W. T.
(2005). Long-Range Interactions between Three Transcriptional Enhancers, Active V{kappa} Gene Promoters, and a 3' Boundary Sequence Spanning 46 Kilobases. Mol. Cell. Biol.
25: 3220-3231
[Abstract]
[Full Text]
-
McDevit, D. C., Perkins, L., Atchison, M. L., Nikolajczyk, B. S.
(2005). The Ig{kappa}3' Enhancer Is Activated by Gradients of Chromatin Accessibility and Protein Association. J. Immunol.
174: 2834-2842
[Abstract]
[Full Text]
-
Yoo, B. S., Boverhof, D. R., Shnaider, D., Crawford, R. B., Zacharewski, T. R., Kaminski, N. E.
(2004). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Alters the Regulation of Pax5 in Lipopolysaccharide-Activated B Cells. Toxicol Sci
77: 272-279
[Abstract]
[Full Text]
-
Yu, D., Allman, D., Goldschmidt, M. H., Atchison, M. L., Monroe, J. G., Thomas-Tikhonenko, A.
(2003). Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway. Blood
101: 1950-1955
[Abstract]
[Full Text]
-
Graf, T.
(2002). Differentiation plasticity of hematopoietic cells. Blood
99: 3089-3101
[Full Text]
-
Emelyanov, A. V., Kovac, C. R., Sepulveda, M. A., Birshtein, B. K.
(2002). The Interaction of Pax5 (BSAP) with Daxx Can Result in Transcriptional Activation in B Cells. J. Biol. Chem.
277: 11156-11164
[Abstract]
[Full Text]
-
EL-Gazzar, M. A., Maeda, K., Nomiyama, H., Nakao, M., Kuwahara, K., Sakaguchi, N.
(2001). PU.1 Is Involved in the Regulation of B Lineage-associated and Developmental Stage-dependent Expression of the Germinal Center-associated DNA Primase GANP. J. Biol. Chem.
276: 48000-48008
[Abstract]
[Full Text]
-
Laurencikiene, J., Deveikaite, V., Severinson, E.
(2001). HS1,2 Enhancer Regulation of Germline {epsilon} and {gamma}2b Promoters in Murine B Lymphocytes: Evidence for Specific Promoter-Enhancer Interactions. J. Immunol.
167: 3257-3265
[Abstract]
[Full Text]
-
Chiang, M. Y., Monroe, J. G.
(2001). Role for Transcription Pax5A Factor in Maintaining Commitment to the B Cell Lineage by Selective Inhibition of Granulocyte-Macrophage Colony-Stimulating Factor Receptor Expression. J. Immunol.
166: 6091-6098
[Abstract]
[Full Text]
-
Kovac, C. R., Emelyanov, A., Singh, M., Ashouian, N., Birshtein, B. K.
(2000). BSAP (Pax5)-Importin alpha 1 (Rch1) Interaction Identifies a Nuclear Localization Sequence. J. Biol. Chem.
275: 16752-16757
[Abstract]
[Full Text]
-
Mikkola, I., Bruun, J.-A., Holm, T., Johansen, T.
(2001). Superactivation of Pax6-mediated Transactivation from Paired Domain-binding Sites by DNA-independent Recruitment of Different Homeodomain Proteins. J. Biol. Chem.
276: 4109-4118
[Abstract]
[Full Text]
-
Anderson, M. K., Sun, X., Miracle, A. L., Litman, G. W., Rothenberg, E. V.
(2001). Evolution of hematopoiesis: Three members of the PU.1 transcription factor family in a cartilaginous fish, Raja eglanteria. Proc. Natl. Acad. Sci. USA
98: 553-558
[Abstract]
[Full Text]